I[ntroduction]{.smallcaps} {#sec1-1}
==========================

Osteoporosis is a bone disorder, characterized by loss of bone strength because of an imbalance between the bone resorption and the mechanisms of bone formation, leading to increased fragility and fractures. Pathophysiological mechanisms underlying this disorder include an inadequate formation response during the remodeling process of bone formation, which is an essential factor in osteoporosis pathogenesis. This inadequacy is due to the activation of large numbers of osteoclasts as a response to initiation of hematopoietic precursor cells with failure of normal interaction with the osteoblastic lineage. This will lead to excessive bone resorption that may result in complete loss of trabecular structure and loss of template for new bone formation. The time required for osteoblastic replacement is longer than the resorption phase of bone remodeling by osteoclasts. Therefore, any increase in bone remodeling will lead to damaged architecture and loss of bone mass.\[[@ref1]\]

Recently, it has been estimated that more than 200 million people worldwide have osteoporosis. On the basis of a statistics from the International Osteoporosis Foundation in 2017, one in five men and one in three women over the age of 50 years will experience fractures during their lifetime because of osteoporosis. Furthermore, it has been found that an osteoporotic fracture occurs every 3s, with the most common fractures occurring at the hip, spine, and wrist.\[[@ref2][@ref3]\]

Osteoporotic fractures may be the first manifestation of the disease, which is why it is called a silent disease. Risk factors of osteoporosis, decreased bone mineral density (BMD), and increased fragility fractures may be modifiable or non-modifiable. Among the modifiable factors are low body mass index (BMI), vitamin D deficiency, low calcium intake, excessive caffeine and alcohol consumption, smoking, sedentary life and low physical activity, endocrine disorders (such as estrogen deficiency and insulin-dependent diabetes mellitus or hyperparathyroidism), some drugs (such as corticosteroids), and previous history of fragility fractures. The non-modifiable factors include female gender, family history, race, and early menopause.\[[@ref4][@ref5]\]

According to the World Health Organization (WHO) diagnostic criteria, osteoporosis is diagnosed by BMD at the hip or spine, which is below the young normal mean reference population by 2.5 standard deviations (SDs) or more. This is called the *T*-score, and osteopenia is diagnosed by BMD less than or equal to 1 SD.\[[@ref6]\]

The guidelines for osteoporosis screening vary greatly in various publications. In general, most organizations recommend that all adults older than 50 years of age with a history of fracture must receive BMD screening.\[[@ref7]\]

Dual-energy X-ray absorptiometry (DXA) at the hip or spine is the best test for measuring central BMD. An association is present between the *T*-score values in DXA in patients with osteoporosis or osteopenia and the risk of fractures. A fracture risk assessment tool (FRAX) was designed. It is estimated that for every 1 SD decline in spine BMD, the risk of having a spine fracture increases 2.3 times and the risk of having a hip fracture increases 2.6 times.\[[@ref8][@ref9]\]

As the most common bone disease in humans, the prevalence of osteoporosis is steadily increasing due to a growing elderly population, and thus represents a major public health concern with reduced bone strength and a higher risk of fractures.\[[@ref6][@ref8]\]

The prevalence of osteoporosis is steadily escalating due to increased life expectancy as a result of developed health services. According to the 2016 WHO report, in the United Arab Emirates (UAE), life expectancy at birth for men was 76 years and for women it was 79 years.\[[@ref10]\]

The UAE population projection showed that in 2011, 7% of the population were 50 years of age or over and less than 1% were 70 years of age or over. By 2050, it is estimated that 12% of the population will be 50 years or over and 2% will be 70 years or over.\[[@ref11]\]

M[aterials and]{.smallcaps} M[ethods]{.smallcaps} {#sec1-2}
=================================================

Study design {#sec2-1}
------------

The study was performed in accordance with the International Conference on Harmonisation Good Clinical Practice guidelines. Ethical approval number UG-H-18-11-7-10 was obtained from the Research Ethics Committee of the college. The study was conducted on a population sample of national and nonnational people in the UAE. Both men and women were recruited in the study. Data were collected from the patients in six governmental and private hospitals.

Research tools {#sec2-2}
--------------

A total of 200 male and female participants between the age of 25 and 80 years were recruited in the study. Eighty percent of the sample were women and 20% were men.

After obtaining the required consent, each participant was asked to fill a structured questionnaire consisting of 25 questions, which was used as the primary tool for data collection. The questions were formulated both in Arabic and English, it required 3--4min to be completed. BMD of the participants was assessed in the International Radiology Centre and correlated with their data in the questionnaires. DXA scan was used for the measurement of BMD.

Data collection and data analysis {#sec2-3}
---------------------------------

After ensuring strict confidentiality, data were collected between March 20, 2016 and May 20, 2016. The following information was obtained:

-   Demographic data (gender, age, race, BMI, and occupation)

-   Family history of osteoporosis or osteoporotic fractures

-   Social history and lifestyle, physical activity, and exposure to the sun

-   Dietary habits such as calcium, caffeine, and soft drinks intake

-   Medical history of diseases and medicines. For female participants, number of pregnancies, lactation, and age at menopause were included

The following criteria were used to evaluate osteoporosis:

-   Normal BMD: if *T*-score between +2.5 and --1

-   Osteopenia: if *T*-score between --1 and --2.5

-   Osteoporosis: if *T*-score below --2.5

The filled questionnaires were coded and data were analyzed statistically using the Statistical Package for the Social Sciences (SPSS) software (version 24; IBM Corporation, Newyork, USA). Spearman's correlation test was carried out to assess the association between different variables in the study. A *P* value of less than 0.05 was considered significant.

R[esults]{.smallcaps} {#sec1-3}
=====================

Sociodemographic data {#sec2-4}
---------------------

The sociodemographic background of the study participants is listed in [Table 1](#T1){ref-type="table"}. A total of 200 participants were included in the study. The control group and the osteoporotic group consisted of 100 participants each, 20% of them were men, whereas 80% of the respondents were women.

###### 

Background demographic data of the respondents

                                Control group (%)   Osteoporotic group (%)   Total
  ----------------------------- ------------------- ------------------------ -------
  Age group                                                                  
   \<35 years                   50.0                6.0                      56.0
   35--50 years                 40.0                18.0                     58.0
   \>50 years                   10.0                76.0                     86.0
  Gender                                                                     
   Male                         20.0                20.0                     40.0
   Female                       80.0                80.0                     160.0
  Occupation                                                                 
   Doctor                       10.0                14.0                     24.0
   Teacher                      8.0                 12.0                     20.0
   Manager                      4.0                 8.0                      12.0
   Engineer                     6.0                 2.0                      8.0
   Housewife                    28.0                52.0                     80.0
   Others                       44.0                12.0                     56.0
  Total number of respondents   100                 100                      200

Body mass index {#sec2-5}
---------------

The patients with osteoporosis have significantly lower BMI than the control group (*P* \< 0.05). Results showed that 72% of them have a BMI less than 25 kg/m^2^ (*P* \< 0.05) \[[Table 2](#T2){ref-type="table"}\] \[[Figure 1](#F1){ref-type="fig"}\].

###### 

Body mass index of the respondents

                                    Control group (%)   Osteoporotic group (%)   Total
  --------------------------------- ------------------- ------------------------ -------
  Body mass index (BMI) (kg/m^2^)                                                
   \<25                             36.0                72\*                     108
   25--30                           54.0\*              22                       76
   \>30                             10.0                6                        16
  Total number of respondents       100                 100                      200

\**P* \< 0.05

![Body mass index (kg/m^2^) of the respondents](JPBS-11-364-g001){#F1}

Smoking behavior {#sec2-6}
----------------

Regarding smoking behavior, a significant value was evident between smoking and osteoporosis (*P* \< 0.01) as 54% of the patients with osteoporosis were current smokers, whereas 72% of the controls had never smoked before \[[Table 3](#T3){ref-type="table"}\] \[[Figure 2](#F2){ref-type="fig"}\].

###### 

Smoking behavior and intake of milk, coffee, and soft drinks by the respondents

                                Control group (%)   Osteoporotic group (%)   Total
  ----------------------------- ------------------- ------------------------ -------
  Smoking behavior                                                           
   Current smoker               22.0                54.0\*\*                 76.0
   Ex-smoker                    6.0                 10.0                     16.0
   Never smoke                  72.0\*\*            36.0                     108.0
  Intake of milk                                                             
   0 glass                      24.0                68.0\*\*                 92.0
   1 glass                      60.0\*\*            24.0                     84.0
   2 and more glasses           16.0                8.0                      24.0
  Intake of coffee or tea                                                    
   0 cup                        32.0                2.0                      34.0
   1 cup                        38.0\*\*            14.0                     52.0
   2 cups                       18.0                24.0                     42.0
   \>2 cups                     12.0                60.0\*\*                 72.0
  Intake of soft drinks                                                      
   0 glass                      62.0\*\*            22.0                     84.0
   1 glass                      24.0                40.0                     64.0
   2 and more glasses           14.0                38.0\*\*                 52.0
  Total number of respondents   100                 100                      200

\*\**P* \< 0.01

![Intake of milk and caffeine and smoking behavior by the respondents](JPBS-11-364-g002){#F2}

Dietary calcium intake {#sec2-7}
----------------------

The intake of milk and dairy products by the participants was used to assess the dietary calcium intake. The patients with osteoporosis have a significant low calcium intake (*P* \< 0.01), whereas non-osteoporotic control significantly consume more milk and dairy products (*P* \< 0.01). A positive correlation was found between the intake of milk and dairy products and the *T*-score value of the participants (*P* \< 0.05) \[[Table 3](#T3){ref-type="table"}\] \[[Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}\].

![Correlation between milk intake and *T*-score in patients with osteoporosis](JPBS-11-364-g003){#F3}

Caffeine consumption {#sec2-8}
--------------------

Caffeine intake was evaluated in this study by the amount of coffee, tea, or soft drinks consumed by the participants each day. The results showed that the patients with osteoporosis significantly consume more caffeine (*P* \< 0.01). A negative correlation is present between the amount of caffeine intake and *T*-score value of the participants (*P* \< 0.05) \[[Table 3](#T3){ref-type="table"}\] \[[Figures 2](#F2){ref-type="fig"}, [4](#F4){ref-type="fig"}, and [5](#F5){ref-type="fig"}\].

![Correlation between tea/coffee intake and *T*-score in patients with osteoporosis](JPBS-11-364-g004){#F4}

![Correlation between soft drinks intake and *T*-score in patients with osteoporosis](JPBS-11-364-g005){#F5}

Exercise behavior and exposure to the sun {#sec2-9}
-----------------------------------------

Results showed a significant positive correlation between the duration of exercise and the *T*-score value of the participants (*P* \< 0.05) \[[Table 4](#T4){ref-type="table"}\] \[[Figure 6](#F6){ref-type="fig"}\].

###### 

Exercise behavior and exposure to sun of the respondents

                                         Control Group   Osteoporotic Group   Total
  -------------------------------------- --------------- -------------------- -------
  \% of respondent do exercise           62.0\*\*        26.0                 88.0
  Exposure to the Sun (3-4 times/week)                                        
   0 -- 5 minutes                        8.0             74.0\*\*             82.0
   6 -- 15 minutes                       20.0            22.0                 42.0
   16 -- 30 minutes                      72.0\*\*        4.0                  76.0
  Total number of respondents            100             100                  200

\*\**P* \< 0.01

![Correlation between exercise duration and *T*-score in patients with osteoporosis](JPBS-11-364-g006){#F6}

Regarding the exposure to the sun, the results showed that 96% of the patients with osteoporosis were exposed to the sun for less than 15min, three to four times a week or not exposed at all, whereas most of the normal controls (72%) exposed their bodies to the sun for 16--30min/day, three to four times a week \[[Table 4](#T4){ref-type="table"}\] \[[Figure 7](#F7){ref-type="fig"}\].

![Sun exposure behavior of the respondents](JPBS-11-364-g007){#F7}

Diseases and medications {#sec2-10}
------------------------

Results of the study revealed that 46% of the patients with osteoporosis were diabetic, 42% of them were treated by antidiabetics, 18% had arthritis and 38% had been treated previously by corticosteroids \[[Table 5](#T5){ref-type="table"}\].

###### 

Distribution of patients with osteoporosis by their diseases and medications

                                                         Osteoporotic group (%)
  ------------------------------------------------------ ------------------------
  Type of disease among the patients with osteoporosis   
   Diabetes                                              46.0
   Arthritis                                             18.0
   Chronic liver/kidney disease.                         16.0
   Hyperthyroidism                                       10.0
   Malabsorption                                         6.0
   Cancer                                                4.0
  Treatment-seeking behavior                             
   Antidiabetics                                         42.0
   Corticosteroids                                       38.0
   Immunosuppressant                                     8.0
   Chemotherapy                                          6.0
   No medicine                                           6.0
  Number of respondents with osteoporosis                100

Number of pregnancies and breastfeeding {#sec2-11}
---------------------------------------

Female participants constituted 80% of the study sample, 75% of the females with osteoporosis were menopausal, 75% of them had three or more pregnancies, and 82.5% of them breastfed their children, whereas these values for the control group participants are 30%, 28%, and 33%, respectively. Results showed a significant positive correlation between the age at menopause and the *T*-score value of females with osteoporosis (*P* \< 0.05) \[[Table 6](#T6){ref-type="table"}\] \[[Figure 8](#F8){ref-type="fig"}\]. The distribution of patients according to the joint affected by Osteoporosis or Osteopenia is shown in \[[Figure 9](#F9){ref-type="fig"}\] and \[[Table 7](#T7){ref-type="table"}\].

###### 

Distribution of female patients with osteoporosis by number of pregnancies and breastfeeding

                                                         Osteoporotic group (%)
  ------------------------------------------------- ---- ------------------------
  Number of pregnancies                                  
   0                                                6    7.5
   1                                                8    10.0
   2                                                10   12.5
   3                                                14   17.5
   4 and more                                       42   52\. 5
  \% of female that breastfed their children        66   82.5
  \% of female respondents that reached menopause   60   75.0
  Number of female respondents with osteoporosis    80   100

![Correlation between age at menopause and *T*-score in female patients with osteoporosis](JPBS-11-364-g008){#F8}

![Distribution of patients having osteopenia or osteoporosis in wrists, hips, or spine](JPBS-11-364-g009){#F9}

###### 

Distribution of patients having osteoporosis and/or osteopenia in hips, wrists, and spine

           Osteopenia (%)   Osteoporosis (%)
  -------- ---------------- ------------------
  Hips     23               29
  Wrists   33               33
  Spine    44               33

D[iscussion]{.smallcaps} {#sec1-4}
========================

To maintain normal bone structure, a remodeling process that consists of osteoclasts, removing old bone, and osteoblasts, synthesizing new bone, occurs. Hematopoietic progenitors produce osteoclasts, whereas mesenchymal stem cells called marrow stromal fibroblasts produce osteoblasts. This process is controlled by certain circulating hormones, growth factors, and locally produced cytokines through their effects on apoptosis of osteoblasts and osteoclasts. Estrogen deficiency or glucocorticoid excess leads to bone loss because of changes in the production of bone cells. This is caused by the prolongation of the life span of osteoclasts and the shortening of the life span of osteoblasts. On the contrary, drugs that aim to treat or prevent osteoporosis prevent apoptosis of osteoblasts and/or stimulate the apoptosis of osteoclasts.\[[@ref12]\]

The pathogenesis of osteoporosis is the consequence of various hormonal, genetic, dietary, lifestyle, and physical factors. Genetic factors mainly affect the BMD and bone formation, whereas low levels of estrogen increase parathyroid hormone, and local cytokines are mainly responsible for bone remodeling imbalance.\[[@ref13]\]

Age and gender {#sec2-12}
--------------

In this study, 76% of the patients with osteoporosis were women at or above 50 years of age. Osteoporosis is usually considered a disease of the elderly with low BMD. In a recent study, most of the patients with osteoporosis were in the age groups of 45--49 and 50--54 years.\[[@ref14]\] Previous studies showed that women were at an increased risk of developing osteoporosis because of their faulty behavior of physical inactivity, sun-avoidance behavior, low intake of dairy products, and poor diets.\[[@ref15][@ref16][@ref17]\]

Body mass index {#sec2-13}
---------------

The results of this study showed a significant number of patients of osteoporosis with BMI \<25 kg/m^2^, where *P* \< 0.05. Women that have low BMI are at a higher risk of developing osteoporosis. It is reported that one unit change in BMI has a larger effect on the risk of developing osteoporosis than most other modifiable risk factors. To help reduce the risk of osteoporosis, patients should be advised to maintain a weight within the normal range.\[[@ref15][@ref16]\] The risk of osteoporotic fractures increases in adults who have low BMI of less than 20 kg/m^2^.\[[@ref18]\]

On the contrary, patients who are obese (BMI \>30 kg/m^2^) are also at a high risk of developing osteoporosis and fractures because of the risk of repeated falls and the weakness of the skeletal muscles due to loss of its mass as a result of aging.\[[@ref19]\]

Exercise and physical activity {#sec2-14}
------------------------------

The results of this study showed a significant correlation between the exercise time and the *T*-score value. Previous studies concluded that physical activity and exercises stimulate skeletal growth and bone strength.\[[@ref4][@ref5]\]

Estrogen {#sec2-15}
--------

Estrogen deficiency has a critical effect on the pathogenesis of osteoporosis. The results of this study showed a significant positive correlation between the age at menopause and the *T*-score value of the female patients. Estrogen has a crucial role in bone formation and physiology. It stimulates the production of T cell cytokines, affects the osteoblastic cell by altering its production of receptor activator of nuclear factor-Kappa B ligand (RANKL) or Osteoprotegerin (OPG), inhibits the differentiation of osteoclasts by direct action, and stimulates the formation of bone performed by osteoblasts and osteocytes, which allows them to enhance their ability to respond to mechanical forces.\[[@ref20][@ref21]\]

Estrogen produces its effect through a specific cell surface receptor called the estrogen receptor alpha (ERα). This receptor binds and then transports estrogen into the nucleus of the cell where certain genes are then activated by the receptor--hormone complex. ERα receptors and estrogen receptor--related receptor alpha (ERRα) are found on the surface of osteoblasts. ERRα may play a supporting role in the regulation of bone cells.\[[@ref22]\] Previous studies also suggest that sex hormone--binding globulin may play a significant role in regulating bone cells as well because it facilitates entry of estrogen into cells.\[[@ref23]\]

Because of the natural drop of estrogen level in postmenopausal women, they are at the highest risk of developing osteoporosis. A previous study showed that it is an increase in bone resorption that might be the driving force for bone loss during estrogen deficiency in postmenopausal women not impaired bone formation as was previously thought.\[[@ref1]\] However, other studies indicated that both markers of bone resorption and formation also increased, leading to accelerated bone remodeling at menopause.\[[@ref24][@ref25]\]

Calcium intake and vitamin D {#sec2-16}
----------------------------

Calcium and vitamin D are two pivotal contributors of bone formation and mineralization. The results of this study showed that the patients with osteoporosis have a significant low calcium intake, whereas controls significantly consume more milk and dairy products (*P* \< 0.01). This significant result showed the importance of calcium intake. Results also established a positive correlation between calcium intake and the *T*-score value of the participants.

Vitamin D plays an important role in maintaining calcium homeostasis and bone integrity as it is essential for intestinal calcium absorption.\[[@ref26]\]

It is estimated that over one billion people around the world have vitamin D deficiency.\[[@ref27][@ref28]\]

Sun exposure is considered as the source of vitamin D, the present results showed a significant value (*P* \< 0.01) as 74% of the patients with osteoporosis exposed their bodies to the sun for 5min or less, three to four times per week, whereas 72% of controls exposed their bodies to the sun for 15--30min, 3 to 4 times a week. A previous study conducted in the UAE showed that 58.2% of the UAE nationals were vitamin D deficient compared to 45% of the patients from other nationalities.\[[@ref29]\]

In spite of living in sunny areas, such as UAE, Saudi Arabia, and India, young populations have a high prevalence of vitamin D deficiency because of insufficient knowledge and practice of vitamin D and its health implications.\[[@ref30][@ref31]\]

Decreased blood calcium level will lead to secondary hyperparathyroidism. This decrease may result from impaired intestinal calcium absorption due to vitamin D deficiency, aging, or other diseases. Calcitriol, the active form of vitamin D, stimulates the intestinal absorption of calcium and phosphorus. It has an inhibitory effect on the synthesis of parathyroid hormone as well. Therefore, calcitriol deficiency will lead to secondary hyperparathyroidism as well.\[[@ref32]\]

There is a clear evidence that the risk of having an osteoporotic fracture increases when vitamin D levels are below 50 nmol.\[[@ref33][@ref34]\]

However, a recent study showed that pathological macrophages produced by vitamin D receptor signaling play an important role in the development of myelofibrosis.\[[@ref35]\]

Smoking {#sec2-17}
-------

The results of this study showed that nicotine has a significant effect on the incidence of osteoporosis (*P* \< 0.01). Smoking has been identified as a modifiable risk factor for low BMD and increased osteoporotic fracture risk.\[[@ref36][@ref37]\]

Smoking behavior should be evaluated when assessing the fracture risk and FRAX.\[[@ref16][@ref38]\]

The role of smoking in decreasing BMD is complicated; smoking is shown to be associated with other risk factors for osteoporosis such as decreased physical activity, low BMI, and poor diet.\[[@ref38]\]

Nicotine has both direct and indirect effects on BMD. The direct effect is on bone cell proliferation and is described to be biphasic, small doses have a stimulatory effect, whereas toxic large doses have an antiproliferative effect on the proliferation of osteoblasts.\[[@ref39]\]

This effect on osteoblasts is receptor mediated by the nicotinic acetylcholine receptors, where nicotine in low doses upregulates gene expression of alkaline phosphatase, type 1 collagen, and osteocalcin.\[[@ref40]\]

Nicotine produces an increased level of tumor necrosis factor α (TNFα) secretion that reduces bone formation by osteoblasts and increases bone resorption by osteoclasts. TNFα has a powerful osteoclastogenic effect through its stimulating effect on RANKL production and by intensifying osteoclasts production.\[[@ref41]\]

It is strongly supported that RANK/RANKL/OPG systems have a role in regulating bone resorption and the formation of osteoclasts.\[[@ref42]\] The main predisposing factor for chronic obstructive pulmonary disease (COPD) has been found to be smoking. The most important factor in managing COPD continues to be the termination of smoking.\[[@ref43]\] It has been shown in numerous studies that smokers with COPD have elevated levels of pro-inflammatory cytokines in the form of interleukin-6. In addition, TNFα levels are much higher in COPD smokers than in asymptomatic smokers. This indicates that COPD affects local and systemic inflammatory responses, which in turn affects bone remodeling.\[[@ref44][@ref45]\] Nicotine has an indirect effect on BMD, which is caused by releasing calcitropic hormones and glucocorticoids, which leads to an increase in bone resorption.\[[@ref43]\] Furthermore, smoking has been linked to an increase in the level of cortisol\[[@ref44][@ref46]\] as well as a decrease in the level of estradiol.\[[@ref47]\] Nicotine also harms intestinal calcium absorption, which might lessen the effectiveness of dietary calcium supplements.\[[@ref48]\] Also, toxic carcinogenic metabolites of nicotine have also been found to increase osteoclast formation in rats.\[[@ref49]\] Moreover, one hip fracture in eight postmenopausal women with osteoporosis is attributable to smoking. This correlation could not be explained by early menopause, low BMI, lower levels of exercise, or by the actions of nicotine on estrogen. This indicates that there is an independent negative effect of nicotine on BMD, which means that smokers lose bone at a faster rate than nonsmokers.\[[@ref50]\]

C[onclusion]{.smallcaps} {#sec1-5}
========================

Prevalence of osteoporosis is high in the UAE and is expected to grow due to increased life expectancy and faulty lifestyle of inadequate dietary habits, sun exposure, exercise behavior, and smoking. More intervention should be directed toward changing the modifiable risk factors in the patients with osteoporosis, and more studies should be directed toward osteoporosis in the UAE.

Limitations of the study {#sec2-18}
------------------------

To make the study a polycentric research, it would require greater number of participants from all the emirates of the UAE.
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